(2025). Relationship of Diabetes Distress and Depressive Symptoms with Medication Adherence among Patients with Type 2 Diabetes Mellitus Attending Family Medicine Units/Centers in Port Said City. The Egyptian Journal of Hospital Medicine, 98(1), 1254-1266. doi: 10.21608/ejhm.2025.418843
. "Relationship of Diabetes Distress and Depressive Symptoms with Medication Adherence among Patients with Type 2 Diabetes Mellitus Attending Family Medicine Units/Centers in Port Said City". The Egyptian Journal of Hospital Medicine, 98, 1, 2025, 1254-1266. doi: 10.21608/ejhm.2025.418843
(2025). 'Relationship of Diabetes Distress and Depressive Symptoms with Medication Adherence among Patients with Type 2 Diabetes Mellitus Attending Family Medicine Units/Centers in Port Said City', The Egyptian Journal of Hospital Medicine, 98(1), pp. 1254-1266. doi: 10.21608/ejhm.2025.418843
Relationship of Diabetes Distress and Depressive Symptoms with Medication Adherence among Patients with Type 2 Diabetes Mellitus Attending Family Medicine Units/Centers in Port Said City. The Egyptian Journal of Hospital Medicine, 2025; 98(1): 1254-1266. doi: 10.21608/ejhm.2025.418843
Relationship of Diabetes Distress and Depressive Symptoms with Medication Adherence among Patients with Type 2 Diabetes Mellitus Attending Family Medicine Units/Centers in Port Said City
Background: Diabetes distress and depression are known barriers to medication adherence in patients with type 2 diabetes. Limited research has explored this relationship in patients treated at Egyptian family health facilities. Objectives: To assess the association of diabetes distress and depressive symptoms with medication adherence among people with type 2 diabetes attending family medicine units/centers in Port Said City. Patients and Methods: A cross-sectional analytic study included 370 diabetic patients from 5 family health facilities in Port Said City, used convenient sampling. Data were collected using a semi-structured questionnaire, including demographic, disease profiles, the Diabetes Distress Scale (DDS-17), the Patient Health Questionnaire (PHQ-9), the General Medication Adherence Scale (GMAS), and recent HbA1c results. Results: Suboptimal medication adherence (77.03%), depressive symptoms (28.38%), and diabetes distress (35.41%) were prevalent among the participants. Multiple logistic regression analysis revealed that predictors of optimal medication adherence included female gender (OR 2.470, P=0.013), sufficient income (OR 4.703, P<0.001), absence of dyslipidemia (OR 0.273, P=0.002), and absence of depressive symptoms (OR 0.197, P=0.003). Diabetes distress was clinically associated with suboptimal medication adherence, but this association was not statistically significant. Conclusion: Depressive symptoms were associated with suboptimal medication adherence. While diabetes distress showed a clinical link to suboptimal adherence, it was not statistically significant. These findings emphasize the importance of addressing depressive symptoms and monitoring diabetes distress in clinical practice to improve medication adherence.
View on SCiNiTO
Top